Dewpoint Therapeutics
Cambridge · 1 people tracked
Investment thesis
Dewpoint applies condensate biology to unlock therapeutic opportunities by modulating biomolecular condensates—the membraneless organelles that organize cellular functions. The company's proprietary AI-powered platform targets historically undruggable proteins and pathways across oncology, neurology, and cardiometabolic disease. This approach is validated by the clinical advancement of DPTX3186, a first-in-class beta-catenin modulator, which demonstrates that condensate modulation can translate to clinically actionable medicines addressing significant unmet medical needs.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directories
Frequently asked questions
- What sectors does Dewpoint Therapeutics focus on?
- Dewpoint Therapeutics focuses on Biotech.
- Where is Dewpoint Therapeutics located?
- Dewpoint Therapeutics is headquartered in Cambridge, US.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.